Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
K-M. Schützer
Institution:
AstraZeneca (Sweden)
Observed institution:
AstraZeneca (Sweden)
OpenAlex ID:
A5111466547
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
2011
·
M. Nowicki
, I. Rychlik
, et al.
·
International Journal of Clinical Practice
·
136
PDF
Show more works
View as search
Works count:
1
Citation count:
136
H-index:
1
I10-index:
1
Year
Topic
Type